CN1084198C - Psoriasis treating Chinese medicine bolus - Google Patents

Psoriasis treating Chinese medicine bolus Download PDF

Info

Publication number
CN1084198C
CN1084198C CN99112425A CN99112425A CN1084198C CN 1084198 C CN1084198 C CN 1084198C CN 99112425 A CN99112425 A CN 99112425A CN 99112425 A CN99112425 A CN 99112425A CN 1084198 C CN1084198 C CN 1084198C
Authority
CN
China
Prior art keywords
accounts
gross weight
chinese medicine
psoriasis
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99112425A
Other languages
Chinese (zh)
Other versions
CN1267541A (en
Inventor
杨庆甲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99112425A priority Critical patent/CN1084198C/en
Publication of CN1267541A publication Critical patent/CN1267541A/en
Application granted granted Critical
Publication of CN1084198C publication Critical patent/CN1084198C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a psoriasis treating Chinese medicine bolus which is prepared from prism tuber, rhizoma zedoariae. Dictamnus, tree peony bark, rehmannia root, red peony root, angelica, isatis root, centipede, black snake, long-noded pit viper and stiff silkorm through processing according to reasonable proportions. The medicine has high cure rate for treating psoriasis and no side effect, and can be widely applied to various types of psoriasis.

Description

The psoriasic Chinese medicine pill of a kind of treatment
The invention belongs to the psoriasic special-purpose medicaments of treatment, the psoriasic Chinese medicine pill of specifically a kind of treatment.
Psoriasis also is psoriasis, for the cause of disease consistent definite saying is not also arranged at present.This disease takes place quite anxious to skin lesion, be initially the big red pimple of the syringe needle or the grain of rice, there is a small amount of white squama on the surface, and later pimple enlarges fusion gradually, becomes the speckle that fingernail, coin or hand size do not wait, clear border, substrate is rubescent, can become the sheet infringement of different shape by several piece to there not being several piece, the orlop squama is more firm, exposes scarlet shiny surface after wiping off.Psoriasis often betides extremity and stretches face, scalp, sacrum portion and trunk, and many symmetries take place, and slight pruritus is arranged, though to the health of human body moment-less influence, stimulate very much people's the psychology of liking to be beautiful, has therefore caused that many medical personnels treat research.Psoriasis can disappear voluntarily, but outbreak repeatedly can be delayed the several years to many decades, and primary disease is diagnosed easily, but is difficult to cure.The method for the treatment of primary disease for many years has multiple, and Western medicine is arranged, and Chinese medicine is also arranged, and medicine for external use is arranged, and oral medicine is also arranged, and what also have uses native folk prescription, as external soil folk prescription medicine is: with 5-10% Purified Goa powder ointment, and 5% ammoniated mercury oil or compound benzoic acid ointment; Sulfur 50g, Pericarpium Zanthoxyli 50g, 5 in egg, butter are an amount of, through processing, on warm fire, dry, and pulverize again, the furnishing pasty state is wiped outward.Medicine at present commonly used has following several, and the Western medicine class has: the bimolane capsule, and oral, the side effect of this kind medicine is bigger, can cause nausea after taking, vomiting, stomach receive, even leukocyte descends or inducing leukemia, takes so plant the medicine few people; The enlightening silver strip, oral, main component is active polypeptide, aminoacid, trace element, to improve body immunity, microcirculation improvement, blood viscosity lowering, keep normal human's Proteometabolism and various trace elements balance, mediator's body surface cornu cutaneum protein cell proliferation and to be divided into mechanism, reach and eliminate psoriasic purpose, but the side reaction of this medicine is still more obvious, and clothes backs is thirsty, hyperhidrosis, pruritus, mucosa drying, desquamation, and cure rate is lower.The Chinese medicine class has: XIAOYIN PIAN and tinea health ball, main component is: medicines such as the Radix Rehmanniae, Radix Sophorae Flavescentis, Flos Lonicerae, Folium Isatidis, Radix Paeoniae Rubra, Radix Saposhnikoviae, with clearing away heat and cooling blood, blood enriching and dryness moistening, dispelling wind for relieving itching is mechanism, reach the psoriasic purpose of treatment, this medicine has obvious suppression capillary permeability and antiinflammatory action, have no side effect, but only effective to blood heat wind-dryness type psoriasis and blood-deficiency and wind-dry type psoriasis; Also has a kind of FUFANG QINGDAI WAN that is, main component is medicines such as Indigo Naturalis, Rhizoma Smilacis Glabrae, Radix Salviae Miltiorrhizae, the Radix Angelicae Dahuricae, Massa Medicata Fermentata, with c-mye level, inhibition colo-16 proliferation of cells in heat-clearing and toxic substances removing, eliminating blood stasis and removing ecchymoses, dispelling wind for relieving itching, the reduction epithelial cells is mechanism, reach the psoriasic purpose of treatment, this medicine is applicable to that the homeliness type psoriasis carries out phase, pityriasis rosea, drug eruption, psoriasis cure rate to other types is lower, therefore, the total cure rate of this kind medicine is about 53%, in addition, this medicine has side effect to individual patient, as suffering from diarrhoea.
The object of the present invention is to provide to psoriasis cure rate height, applicable to various psoriasiss and there is not the psoriasic Chinese medicine pill of a kind of treatment of obvious adverse reaction.
The present invention is achieved in that the psoriasic Chinese medicine pill of this a kind of treatment, by heat-clearing and detoxifying herb, blood-activating and stasis-removing, damp eliminating tissue regeneration promoting Chinese medicine, process by rational proportion, this a kind of component and proportioning for the treatment of psoriasic Chinese medicine pill is: rhizoma sparganic accounts for the 4-12% of gross weight, Rhizoma Curcumae accounts for the 4-13% of gross weight, Cortex Dictamni accounts for the 4-13% of gross weight, Cortex Moutan accounts for the 4-13% of gross weight, the Radix Rehmanniae accounts for the 4-13% of gross weight, Radix Paeoniae Rubra accounts for the 4-13% of gross weight, Radix Angelicae Sinensis accounts for the 4-16% of gross weight, Radix Isatidis accounts for the 4-16% of gross weight, Scolopendra accounts for the 1-5% of gross weight, Zaocys accounts for the 4-17% of gross weight, Agkistrodon accounts for the 4-13% of gross weight, Bombyx Batryticatus accounts for the 4-11% of gross weight.Its production process is: at first carry out selected to used component, remove impurity, take by weighing the weight of each component then by proportioning, remix, behind the mix homogeneously, being ground into fineness with pulverizer is 75-85 purpose fine powder, utilizes pellet processing machine to be condensed into the watered pill at last, is the psoriasic Chinese medicine pill patent medicine of this a kind of treatment after the packing.
Consumption and the method for taking are: oral, three times on the one, each 9g was promptly healed in Time of Administration 1-3 month.This medicine existing 120 people take, and average cure rate is 82.5%, and improvement rate is 91.6%, cures that relapse rate is 5% in the example, the person that do not find the apparent side effect.
Advantage of the present invention is: compare with the antipsoriatics thing of present application, cure rate is higher, has no side effect, applicable to various types of psoriatics.
Embodiment 1
Choose raw material through the selected mistake of remove impurity, produce 100kg patent medicine, need weighing to be: rhizoma sparganic 8kg, Rhizoma Curcumae 8.5kg, Cortex Dictamni 8.5kg, Cortex Moutan 8.5kg, Radix Rehmanniae 8.5kg, Radix Paeoniae Rubra 8.5kg, Radix Angelicae Sinensis 10kg, Radix Isatidis 10kg, Scolopendra 3kg, Zaocys 10.5kg, Agkistrodon 8.5kg, Bombyx Batryticatus 7.5kg, with the raw material mix homogeneously that takes by weighing, be ground into 80 purpose fine powders with pulverizer, the reuse pellet processing machine is condensed into the watered pill, is packaged as finished product.This embodiment takes through 40 patients, and effective percentage is 95%, and cure rate is 87.5%, cures relapse rate 2.5% in the example, and especially to the blood heat wind-dryness type psoriasis, cure rate is 96.8%.After oral, promptly took an evident turn for the better in 1 month, promptly complete in 2 months, find no side effect person.
Embodiment 2
Raw material is handled with embodiment 1.Produce 100kg patent medicine, weighing is: rhizoma sparganic 5kg, Rhizoma Curcumae 10kg, Cortex Dictamni 6kg, Cortex Moutan 11kg, Radix Rehmanniae 4kg, Radix Paeoniae Rubra 11kg, Radix Angelicae Sinensis 6kg, Radix Isatidis 14kg, Scolopendra 1kg, Zaocys 10kg, Agkistrodon 12kg, Bombyx Batryticatus 10kg.Behind mix homogeneously, be ground into 85 purpose fine powders with pulverizer, the reuse pellet processing machine is condensed into the watered pill, is packaged as finished product.This embodiment takes through 40 psoriatics, and effective percentage is 92.5%, and cure rate is 82.5%, and relapse rate is 5% in the healing example.
Embodiment 3
Raw material is handled with embodiment 1.Produce 100kg patent medicine, the amount of taking by weighing is: rhizoma sparganic 12kg, Rhizoma Curcumae 6kg, Cortex Dictamni 13kg, Cortex Moutan 6kg, Radix Rehmanniae 13kg, Radix Paeoniae Rubra 6kg, Radix Angelicae Sinensis 16kg, Radix Isatidis 7kg, Scolopendra 5kg, Zaocys 6kg, Agkistrodon 5kg, Bombyx Batryticatus 5kg.Behind the mix homogeneously, be ground into 75 purpose fine powders, the reuse pellet processing machine is condensed into the watered pill, is packaged as finished product.This embodiment takes through 40 people, and effective percentage is 87.5%, and cure rate is 77.5%, and relapse rate is 10% in the healing example, does not find side effect person.

Claims (1)

1, the psoriasic Chinese medicine pill of a kind of treatment, by heat-clearing and detoxifying herb, blood-activating and stasis-removing, damp eliminating tissue regeneration promoting Chinese medicine, process by rational proportion, it is characterized in that: this component and proportioning for the treatment of psoriasic Chinese medicine pill is: rhizoma sparganic accounts for the 4-12% of gross weight, Rhizoma Curcumae accounts for the 4-13% of gross weight, Cortex Dictamni accounts for the 4-13% of gross weight, Cortex Moutan accounts for the 4-13% of gross weight, the Radix Rehmanniae accounts for the 4-13% of gross weight, Radix Paeoniae Rubra accounts for the 4-13% of gross weight, Radix Angelicae Sinensis accounts for the 4-16% of gross weight, Radix Isatidis accounts for the 4-16% of gross weight, Scolopendra accounts for the 1-5% of gross weight, Zaocys accounts for the 4-17% of gross weight, Agkistrodon accounts for the 4-13% of gross weight, Bombyx Batryticatus accounts for the 4-11% of gross weight.
CN99112425A 1999-09-10 1999-09-10 Psoriasis treating Chinese medicine bolus Expired - Fee Related CN1084198C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99112425A CN1084198C (en) 1999-09-10 1999-09-10 Psoriasis treating Chinese medicine bolus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99112425A CN1084198C (en) 1999-09-10 1999-09-10 Psoriasis treating Chinese medicine bolus

Publications (2)

Publication Number Publication Date
CN1267541A CN1267541A (en) 2000-09-27
CN1084198C true CN1084198C (en) 2002-05-08

Family

ID=5275735

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99112425A Expired - Fee Related CN1084198C (en) 1999-09-10 1999-09-10 Psoriasis treating Chinese medicine bolus

Country Status (1)

Country Link
CN (1) CN1084198C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094861A1 (en) * 2004-04-02 2005-10-13 Sung-Bae Park Composition for treating psoriasis-associated diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1052901A (en) * 1989-12-28 1991-07-10 本溪冶炼厂 With alkaline-earth metal production NEW TYPE OF COMPOSITE deoxidant Si-Al-Ba-Fe alloy alloy
CN1265312A (en) * 2000-01-13 2000-09-06 杨文喜 Psoriasis treating medicine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1052901A (en) * 1989-12-28 1991-07-10 本溪冶炼厂 With alkaline-earth metal production NEW TYPE OF COMPOSITE deoxidant Si-Al-Ba-Fe alloy alloy
CN1265312A (en) * 2000-01-13 2000-09-06 杨文喜 Psoriasis treating medicine

Also Published As

Publication number Publication date
CN1267541A (en) 2000-09-27

Similar Documents

Publication Publication Date Title
CN102018937B (en) Medicament for treating acne and preparation method thereof
CN1315525C (en) Chinese traditional medicine for treating breast disease and preparing technique
CN101306175A (en) Medicine for treating whelk, comedo and acne
CN101884696A (en) Honeyed pill formulation capable of promoting hair to be regenerated and hair to become black
CN101297889B (en) Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof
CN101422530A (en) Traditional Chinese medicine for treating upper right front-tooth pyretic toothache
CN1351872A (en) Chinese herbal medicine for curing comedo and acne
CN101757444A (en) Orally administrated medicine for Chinese traditional treatment of thyroid nodule
CN1084198C (en) Psoriasis treating Chinese medicine bolus
CN101757595A (en) Traditional Chinese medicine composition for treating vomiting of pregnancy and preparation method thereof
CN1180821C (en) Medicine for treating cerebral thrombus and its prepn
CN1261130C (en) Medicine for dispelling tinea
CN101683500A (en) Chinese herbal medicine external ointment for treating folliculitis and preparation method thereof
CN1063650C (en) Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method
CN1451405A (en) Chinese medicine plaster for treating psoriasis
CN1194733C (en) Medicine for treating hyperthyroidism and its prepn
CN1415344A (en) Specific medicine of natural plants for curing sprain
CN1876082A (en) A Chinese medicine for treating femoral head necrosis and preparation method thereof
CN101757318A (en) Dehumidifying pill
CN1073426C (en) Medicine for lithiasis
CN105343705A (en) Rheumatoid arthritis treatment medicine
CN1403123A (en) Notoginseng medicine for treating traumatic injury and its prepn
CN101297951A (en) Pellet for soothing nerve and releasing depression
CN105055987A (en) Psoriasis treating traditional Chinese medicine preparation and preparation method thereof
CN1094355C (en) Yugan pill for curing hepatitis and ascites due to cirrhosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee